Magnesium and Letermovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium (magnesium) and Letermovir (letermovir). Common drug interactions include septic shock among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium and Letermovir. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,145 Magnesium users. Check the latest studies of Magnesium.

What is Letermovir?

Letermovir has active ingredients of letermovir. eHealthMe is studying from 949 Letermovir users. Check the latest studies of Letermovir.



On Aug, 08, 2026

38 people who take Magnesium and Letermovir together, and have interactions are studied.

Magnesium and Letermovir drug interactions.

What are the common drug interactions of Magnesium and Letermovir, by gender? *:

female:

  1. Septic shock (shock due to blood infection)
  2. Abdominal pain
  3. Back pain
  4. Chest discomfort
  5. Dyspepsia (indigestion)
  6. Dysuria (painful or difficult urination)
  7. Hepatic enzyme increased
  8. Hypotension (abnormally low blood pressure)
  9. Lymphoma (cancer that begins in immune system cells)
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

male:

  1. Gait disturbance
  2. Oesophagitis (inflammation of oesophagus)
  3. Electrolyte imbalance
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Mucosal inflammation (infection of mucous membrane)
  6. Muscular weakness (muscle weakness)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Osteonecrosis (death of bone)
  9. Platelet count decreased
  10. Procedural pain

What are the common drug interactions of Magnesium and Letermovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)

10-19:

  1. Pyrexia (fever)
  2. Abscess (pus)
  3. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  4. Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
  5. Blood sodium decreased
  6. Drug eruption (adverse drug reaction of the skin)
  7. Drug hypersensitivity
  8. Electrolyte imbalance
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Mucosal inflammation (infection of mucous membrane)

20-29:

  1. Oesophagitis (inflammation of oesophagus)

30-39:

  1. Brain abscess
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

n/a

50-59:

  1. Lymphoma (cancer that begins in immune system cells)
  2. Septic shock (shock due to blood infection)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. Blood pressure increased
  7. Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
  8. Cough
  9. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  10. Dysplasia (enlargement of an organ or tissue)

60+:

  1. Gait disturbance
  2. Confusional state
  3. Hypotension (abnormally low blood pressure)
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Muscular weakness (muscle weakness)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Productive cough
  8. Septic shock (shock due to blood infection)
  9. Tachypnoea (a condition of rapid breathing over 20 per minute)
  10. Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 15.79%
  2. Infection: 6 people, 15.79%
  3. High Blood Pressure: 5 people, 13.16%
  4. Cytomegalovirus Infection: 5 people, 13.16%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 13.16%
  6. Pain: 4 people, 10.53%
  7. Encephalitis (inflammation of the brain): 4 people, 10.53%
  8. Nausea (feeling of having an urge to vomit): 3 people, 7.89%
  9. Depression: 3 people, 7.89%
  10. Hypokalemia (low potassium): 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium and Letermovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Magnesium and Letermovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Letermovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Letermovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on magnesium and letermovir (the active ingredients of Magnesium and Letermovir, respectively), and Magnesium and Letermovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: